Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

Towards combinatorial targeted therapy in melanoma: from pre-clinical evidence to clinical application (review).

Grazia G, Penna I, Perotti V, Anichini A, Tassi E.

Int J Oncol. 2014 Sep;45(3):929-49. doi: 10.3892/ijo.2014.2491. Epub 2014 Jun 10.

PMID:
24920406
[PubMed - in process]
Free PMC Article
2.

Evolving pharmacotherapies for the treatment of metastatic melanoma.

Salama AK.

Clin Med Insights Oncol. 2013 Jun 20;7:137-49. doi: 10.4137/CMO.S9565. Print 2013.

PMID:
23843723
[PubMed]
Free PMC Article
3.

The C-kit receptor-mediated signal transduction and tumor-related diseases.

Liang J, Wu YL, Chen BJ, Zhang W, Tanaka Y, Sugiyama H.

Int J Biol Sci. 2013 May 8;9(5):435-43. doi: 10.7150/ijbs.6087. Print 2013. Review.

PMID:
23678293
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

New treatment approaches in melanoma: current research and clinical prospects.

Rughani MG, Gupta A, Middleton MR.

Ther Adv Med Oncol. 2013 Jan;5(1):73-80. doi: 10.1177/1758834012463260.

PMID:
23323148
[PubMed]
Free PMC Article
5.

Expression of Sox10 and c-kit in sinonasal mucosal melanomas arising in the Chinese population.

Liu HG, Kong MX, Yao Q, Wang SY, Shibata R, Yee H, Martiniuk F, Wang BY.

Head Neck Pathol. 2012 Dec;6(4):401-8. doi: 10.1007/s12105-012-0375-2. Epub 2012 Jun 27.

PMID:
22736149
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Melanoma: from mutations to medicine.

Tsao H, Chin L, Garraway LA, Fisher DE.

Genes Dev. 2012 Jun 1;26(11):1131-55. doi: 10.1101/gad.191999.112. Review.

PMID:
22661227
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Malignant melanoma of the conjunctiva: a case report with examination of KIT and PDGFRA.

Terada T.

Rare Tumors. 2012 Jan 2;4(1):e8. doi: 10.4081/rt.2012.e8. Epub 2012 Jan 20.

PMID:
22532924
[PubMed]
Free PMC Article
8.

The current state of targeted therapy in melanoma: this time it's personal.

Smalley KS, McArthur GA.

Semin Oncol. 2012 Apr;39(2):204-14. doi: 10.1053/j.seminoncol.2012.01.008. Review.

PMID:
22484192
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Targeted agents for the treatment of metastatic melanoma.

Monzon JG, Dancey J.

Onco Targets Ther. 2012;5:31-46. doi: 10.2147/OTT.S21259. Epub 2012 Mar 5.

PMID:
22419879
[PubMed]
Free PMC Article
10.

Malignant melanoma of the nasal cavity: a case report with examination of KIT and platelet derived growth factor receptor-α(PDGFRA).

Terada T.

Rare Tumors. 2011 Oct 21;3(4):e54. doi: 10.4081/rt.2011.e54. Epub 2011 Dec 27.

PMID:
22355509
[PubMed]
Free PMC Article
11.

Delving into somatic variation in sporadic melanoma.

Walia V, Mu EW, Lin JC, Samuels Y.

Pigment Cell Melanoma Res. 2012 Mar;25(2):155-70. doi: 10.1111/j.1755-148X.2012.00976.x. Epub 2012 Feb 13. Review.

PMID:
22260482
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant Melanoma.

Ades F, Metzger-Filho O.

Dermatol Res Pract. 2012;2012:259170. doi: 10.1155/2012/259170. Epub 2011 Dec 15.

PMID:
22216021
[PubMed]
Free PMC Article
13.

Targeting the RAS pathway in melanoma.

Ji Z, Flaherty KT, Tsao H.

Trends Mol Med. 2012 Jan;18(1):27-35. doi: 10.1016/j.molmed.2011.08.001. Epub 2011 Sep 30. Review.

PMID:
21962474
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Molecular bases of cutaneous and uveal melanomas.

Gaudi S, Messina JL.

Patholog Res Int. 2011;2011:159421. doi: 10.4061/2011/159421. Epub 2011 Aug 18.

PMID:
21876842
[PubMed]
Free PMC Article
15.

Therapeutic opportunities in noncutaneous melanoma.

Wilkins DK, Nathan PD.

Ther Adv Med Oncol. 2009 Jul;1(1):29-36. doi: 10.1177/1758834009337664.

PMID:
21789111
[PubMed]
Free PMC Article
16.

KIT as a therapeutic target in metastatic melanoma.

Carvajal RD, Antonescu CR, Wolchok JD, Chapman PB, Roman RA, Teitcher J, Panageas KS, Busam KJ, Chmielowski B, Lutzky J, Pavlick AC, Fusco A, Cane L, Takebe N, Vemula S, Bouvier N, Bastian BC, Schwartz GK.

JAMA. 2011 Jun 8;305(22):2327-34. doi: 10.1001/jama.2011.746.

PMID:
21642685
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafish.

Santoriello C, Gennaro E, Anelli V, Distel M, Kelly A, Köster RW, Hurlstone A, Mione M.

PLoS One. 2010 Dec 10;5(12):e15170. doi: 10.1371/journal.pone.0015170.

PMID:
21170325
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells.

Kong Y, Kumar SM, Xu X.

Arch Pathol Lab Med. 2010 Dec;134(12):1740-9. doi: 10.1043/2009-0418-RAR.1. Review.

PMID:
21128770
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanoma.

Godshalk SE, Paranjape T, Nallur S, Speed W, Chan E, Molinaro AM, Bacchiocchi A, Hoyt K, Tworkoski K, Stern DF, Sznol M, Ariyan S, Lazova R, Halaban R, Kidd KK, Weidhaas JB, Slack FJ.

Oncogene. 2011 Mar 31;30(13):1542-50. doi: 10.1038/onc.2010.536. Epub 2010 Nov 29.

PMID:
21119596
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Analysis of the genome to personalize therapy for melanoma.

Davies MA, Samuels Y.

Oncogene. 2010 Oct 14;29(41):5545-55. doi: 10.1038/onc.2010.323. Epub 2010 Aug 9. Review.

PMID:
20697348
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk